Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years-Reference-Cited by-同舟云学术

Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years

Published:2022-04-25 Issue:7 Volume:28 Page:1486-1490
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Arbel Ronen^ORCID,Sergienko Ruslan,Friger Michael,Peretz Alon,Beckenstein Tanya,Yaron Shlomit,Netzer Doron,Hammerman Ariel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-022-01832-0.pdf

Reference25 articles.

1. Burki, T. K. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir. Med. 10, e19 (2022).

2. Bar-On, Y. M. et al. Protection by a fourth dose of BNT162b2 against Omicron in Israel. N. Engl. J. Med. 386, 1712–1720 (2022).

3. EU drug regulator expresses doubt on need for fourth booster dose. Reuters (12 January 2022); https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-says-more-data-needed-impact-omicron-vaccines-2022-01-11/

4. Hunter, D. J. et al. Addressing vaccine inequity: COVID-19 vaccines as a global public good. N. Engl. J. Med. 386, 1176–1179 (2022).

5. Chagla, Z. & Pai, M. COVID-19 boosters in rich nations will delay vaccines for all. Nat. Med. 27, 1659–1660 (2021).

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetics of humoral and cellular immune responses 5 months post-COVID-19 booster dose by immune response groups at the peak immunity phase: An observational historical cohort study using the Fukushima vaccination community survey;Vaccine: X;2024-10

2. Vaccination against COVID-19 in a post-pandemic era;COVID-19: An Update;2024-09-01

3. COVID-19 vaccine updates for people under different conditions;Science China Life Sciences;2024-07-29

4. Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak;Human Vaccines & Immunotherapeutics;2024-06-21

5. Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study;The Lancet Regional Health - Americas;2024-06